Rare Bacterial Meningitis Cases Surge as Teen Vaccinations Drop

Cases of bacterial meningitis have sharply increased in the United States since 2021, a concerning trend following a significant decline after a CDC recommendation in 2005. Doctors attribute this resurgence to mutating bacteria and a drop in adolescent vaccination rates, particularly for booster doses. The Centers for Disease Control and Prevention's (CDC) revised guidance now suggests the meningitis vaccine primarily for "high-risk groups," a departure from its previous universal recommendation for all adolescents.

This potentially fatal infection, caused by Neisseria meningitidis, can progress with alarming speed, leading to severe outcomes like brain swelling, gangrene, and sepsis, with fatalities possible within 24 hours. Even with prompt treatment, about 15% of patients die, and up to 20% of survivors endure lifelong complications such as amputated limbs or hearing impairment. Teenagers and college-aged adults are considered particularly vulnerable due to close living quarters.

The recent surge includes over 500 reported cases in 2024, the highest since 2013, with a specific strain of the Y serogroup being prevalent. Experts criticize the CDC's move to a "shared clinical decision making" model, arguing it creates unnecessary hurdles for parents seeking crucial protection, especially given the vaccine's safety and proven efficacy in preventing devastating outcomes.